PAR is still shaping up well for a run. Exhaustive research report out over the weekend with multi bag valuations, and AGM today.
http://www.fiftyonecapital.com/market-insights/2018/11/24/paradigm-biopharmaceuticals-ltd
Add to My Watchlist
What is My Watchlist?